Fisher & Paykel Healthcare Corporation Limited (OTCPK:FSPKF) Q4 2025 Earnings Conference Call May 27, 2025 6:00 PM ET
Company Participants
Marcus Driller – Vice President of Corporate
Lewis Gradon – Chief Executive Officer
Lyndal York – Chief Financial Officer
Justin Callahan – Vice President of Sales and Marketing
Conference Call Participants
Davinthra Thillainathan – Goldman Sachs Group, Inc.
Lyanne Harrison – Bank of America Merrill Lynch
Daniel Hurren – MST Marquee
Craig Wong-Pan – RBC Capital Markets
Adrian Allbon – Jarden Limited
Sacha Krien – Evans and Partners
Stephen Ridgewell – Craigs Investment Partners
Andrew Paine – CLSA
Marcus Curley – UBS
Matt Montgomerie – Forsyth Barr
Saul Hadassin – Barrenjoey Markets
Vanessa Thomson – Jefferies
Operator
Welcome to the Fisher & Paykel Healthcare’s Results Conference Call. My name is Justin, and I’ll be your operator for today’s call. At this time, everyone except the guest speakers will be in a listen-only mode. Later, we’ll conduct a question-and-answer session. [Operator Instructions] Please note this conference call is being recorded.
I would now like to turn the call over to Marcus Driller, VP, Corporate.
Marcus Driller
Thank you, Justin. Well, good morning, everyone, and welcome to the conference call for Fisher & Paykel Healthcare’s full-year results for the 2025 financial year.
On the call today are Lewis Gradon, Managing Director and Chief Executive Officer; Lyndal York, Chief Financial Officer; Andy Niccol, our Chief Operating Officer; Justin Callahan, VP of Sales & Marketing; and Andrew Somervell, our VP of Products and Technology. Lewis and Lyndal will first provide an overview of the results and then we’ll move on to questions for the team. We will be discussing our results for the 12 months ended 31 March, 2025.
Earlier today we provided our 2025 annual report, including financial statements and commentary on our results